CAR T cell therapy just scored a big win in a new clinical trial—35% of patients with tough-to-treat solid tumors responded to the treatment, and they were 31% less likely to die than those who didn’t get it. Side effects are still a thing, but this is a huge deal since CAR T cells haven’t worked well on solid tumors before. Plus, someone treated 18 years ago is still in remission! Major hope for cancer fighters right now. #CancerResearch #CARTCells #MedicalBreakthrough #Health